Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

SaucerSwap increases total value locked by 300 percent in just one year with support from The Hashgraph Association (THA)




GENEVA, March 20, 2024 /PRNewswire/ — SaucerSwap, an open source and non-custodial crypto trading protocol and the first decentralized exchange (DEX) to launch on Hedera, has recorded a three-fold increase in Total Value Locked (TVL) since it received development funding support from The Hashgraph Association (THA) in 2023. TVL on SaucerSwap increased from approximately $35 million to over $150 million at the beginning of March[1], a 300% surge in less than a year.

SaucerSwap V1 launched in August 2022, based on the Uniswap V2, and while achieving significant success following its initial launch, the protocol faced challenges when it came to capital inefficiencies. This all changed in 2023, when THA identified SaucerSwap as an innovative startup in the space and on-boarded the project to its Innovation Program. Following the provision of funding support by THA, SaucerSwap underwent a period of rapid transformation and launched SaucerSwap V2 in the same year.

Since then, the project has continued to grow at pace. In addition to TVL growing to $150M,  average 24-hour trading volumes soared from roughly $500k to over $6.5M, a 1200% increase in on-chain volume. Coupled with a rise in Unique Active Wallets (UAWs) and a significant uptick in transactions through the Hedera Smart Contract Service (HSCS), the collaboration between THA and SaucerSwap V2 has yielded substantial growth and has significantly contributed to the value creation on the Hedera network.

Kamal Youssefi, President of The Hashgraph Association states, “SaucerSwap has not only benefited from participating in the Hashgraph Innovation Program with ecosystem development funding from The Hashgraph Association, but it has also added value to Hedera by offering a full range of DeFi services for participants and facilitating the deployment of projects on the Hedera network. This is exactly the example of successful collaborations that we look forward to. Given that DeFi development contributes to financial inclusion around the globe by providing a decentralized, accessible, and secure alternative to traditional finance, THA is proud to be supporting this global financial revolution powered by Hedera.”

By building on the Hedera Network, SaucerSwap was able to conduct financial transactions that included token swaps through smart contracts, as well as through its governance model providing a transparent and immutable log of platform policies. With decentralized exchanges serving as the gateways to DeFi, SaucerSwap is at the epicenter of this transformation allowing individuals and organizations to trade digital assets and NFTs in a non custodial way, while also participating in activities such as staking and yield farming.

In addition to using the Hedera Token Service (HTS) and Smart Contract Service, projects can benefit from increased liquidity by creating a liquidity pool on SaucerSwap. Furthermore, with SaucerSwap V2, liquidity providers can allocate capital within specific price ranges instead of uniformly distributing it across all possible prices.

“We chose Hedera as the public ledger for SaucerSwap due to its ability to support our robust DeFi protocol while providing rapid scalability, high performance, and low, predictable transaction fees denominated in USD,” said Peter Campbell, Co-Founder, Operations & Marketing at SaucerSwap. “Hedera’s lack of a mempool also makes it resistant to MEV, ensuring a superior user experience without the risk of front-running. The support from The Hashgraph Association has been invaluable in our journey to build a cutting-edge, user-centric platform. We are confident that with Hedera and THA by our side, we will continue to innovate and deliver exceptional value to our users, even during times of high network demand.”

About The Hashgraph Association

The Hashgraph Association is at the forefront of the digital enablement and empowerment of organizations through the broad adoption of Hedera-powered enterprise-grade solutions and decentralized applications, including funding training, innovation, and venture building programs globally. As a non-profit organization headquartered in Switzerland, The Hashgraph Association supports and funds innovation, research, and development that enables economic inclusion and a digital future for all, with a positive environmental, social, and governance (ESG) impact. For further information about The Hashgraph Association, visit

About SaucerSwap

SaucerSwap is a decentralized exchange (DEX) and automated market maker (AMM) protocol built on the Hedera network, offering users a non-custodial and efficient platform to swap HBAR and HTS tokens. Developed by SaucerSwap Labs, a Florida-based company, SaucerSwap leverages the Hedera Token Service (HTS) and Hedera Smart Contract Service (HSCS) to provide fast, low-cost transactions with finality in 3-5 seconds.

The protocol offers two versions: SaucerSwap V1, based on the Uniswap V2 constant product AMM, and SaucerSwap V2, which introduces concentrated liquidity and multiple fee tiers, allowing liquidity providers to allocate capital more efficiently. SaucerSwap’s unique features include the Liquidity-Aligned Reward Initiative (LARI), a yield-bearing HBAR wrapper, and resistance to Maximal Extractable Value (MEV) attacks.

Governed by the SaucerSwap DAO and supported by the HBAR Foundation and The Hashgraph Association, SaucerSwap aims to drive innovation and long-term sustainability within the Hedera DeFi ecosystem. As of March 2024, SaucerSwap holds a majority market share among Hedera DeFi protocols, with a total value locked (TVL) of $120 million and a cumulative trading volume of $875 million. For more information about SaucerSwap, visit

[1] TVL data as of 7th March 2024


View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading